retatrutide side effects clinical trial results 2024 2025 Tirzepatide vs. Retatrutide: Key Differences Explained ✨ RETATRUTIDE — The Next

It's also an ideal companion for anyone transitioning off GLP-1 medications who wants to preserve the metabolic progress they've made

Semaglutide set the threshold at -15% in 2021, tirzepatide raised it to -21% in 2022, and retatrutide pushed it to -29% by the end of 2025

In animals, reduced food intake and weight loss were closely linked to growth and bone development issues

These plans focus on protein-dense, nutrient-rich meals that are easy to digest, enjoyable to eat, and designed to support healing, without contributing to unwanted weight gain

Tirzepatide (Eli Lilly, 2022) redrew the map with dual GLP-1/GIP mechanism